NO20043110L - Direkte komprimerbare formuleringer av azitromycin - Google Patents

Direkte komprimerbare formuleringer av azitromycin

Info

Publication number
NO20043110L
NO20043110L NO20043110A NO20043110A NO20043110L NO 20043110 L NO20043110 L NO 20043110L NO 20043110 A NO20043110 A NO 20043110A NO 20043110 A NO20043110 A NO 20043110A NO 20043110 L NO20043110 L NO 20043110L
Authority
NO
Norway
Prior art keywords
azithromycin
directly compressible
compressible formulations
formulations
directly
Prior art date
Application number
NO20043110A
Other languages
English (en)
Norwegian (no)
Inventor
Barbara Alice Johnson
Ernest Shing Quan
Brendn John Murphy
Steven William Collier
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20043110L publication Critical patent/NO20043110L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20043110A 2001-12-21 2004-07-20 Direkte komprimerbare formuleringer av azitromycin NO20043110L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34348001P 2001-12-21 2001-12-21
PCT/IB2002/005222 WO2003053416A1 (en) 2001-12-21 2002-12-09 Directly compressible formulations of azithromycin

Publications (1)

Publication Number Publication Date
NO20043110L true NO20043110L (no) 2004-07-20

Family

ID=23346277

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043110A NO20043110L (no) 2001-12-21 2004-07-20 Direkte komprimerbare formuleringer av azitromycin

Country Status (21)

Country Link
US (4) US20030165563A1 (pl)
EP (1) EP1455758A1 (pl)
JP (1) JP2005513099A (pl)
KR (1) KR100632339B1 (pl)
CN (1) CN1668282A (pl)
AR (1) AR037930A1 (pl)
AU (1) AU2002348884A1 (pl)
BR (1) BR0215193A (pl)
CA (1) CA2469246A1 (pl)
IL (1) IL161996A0 (pl)
MX (1) MXPA04005105A (pl)
NO (1) NO20043110L (pl)
NZ (1) NZ532707A (pl)
PA (1) PA8562201A1 (pl)
PE (1) PE20030591A1 (pl)
PL (1) PL371259A1 (pl)
PY (1) PY0231025A (pl)
RU (1) RU2277914C2 (pl)
TW (1) TW200301138A (pl)
WO (1) WO2003053416A1 (pl)
ZA (1) ZA200403486B (pl)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020231A2 (en) * 2002-03-18 2003-12-31 Pliva D D ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
TWI229674B (en) 1998-12-04 2005-03-21 Astra Pharma Prod Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
PL371259A1 (pl) * 2001-12-21 2005-06-13 Pfizer Products Inc. Bezpośrednio sprasowywalne preparaty azytromycyny
FR2834889B1 (fr) * 2002-01-18 2004-04-02 Roquette Freres Forme pharmaceutique solide orodispersible
GB0211620D0 (en) * 2002-05-21 2002-07-03 Bioprogress Technology Ltd Powder compaction and enrobing
US20030228370A1 (en) * 2002-06-11 2003-12-11 Michel Serpelloni Orodispersible solid pharmaceutical form
HRP20020614A2 (en) * 2002-07-22 2004-06-30 PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
EP1648472A2 (en) * 2003-07-01 2006-04-26 Ranbaxy Laboratories, Ltd. Stable oral compositions of azithromycin monohydrate
WO2005004919A2 (en) * 2003-07-02 2005-01-20 Eurand, Inc. Extended release systems for macrolide antibiotics
US20050013835A1 (en) * 2003-07-15 2005-01-20 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
US20050101547A1 (en) * 2003-11-06 2005-05-12 Sadatrezaei Mohsen Stabilized azithromycin composition
CA2547597A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate compositions with improved stability
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
MXPA06005913A (es) * 2003-12-04 2006-06-27 Pfizer Prod Inc Formas de dosificacion de multiparticulas de azitromicina por procedimientos basados en liquidos.
KR100844628B1 (ko) 2003-12-04 2008-07-07 화이자 프로덕츠 인크. 제약상 다입자의 제조 방법
ES2600577T3 (es) * 2003-12-04 2017-02-09 Bend Research, Inc. Procedimiento de pulverización-solidificación que usa un extrusor para preparar composiciones en multipartículas de fármacos cristalinos
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
US7943585B2 (en) 2003-12-22 2011-05-17 Sandoz, Inc. Extended release antibiotic composition
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
CA2591744A1 (en) * 2004-12-21 2006-06-29 Pfizer Products Inc. Stable non-dihydrate azithromycin oral suspensions
US7901710B2 (en) * 2005-08-04 2011-03-08 Vertical Pharmaceuticals, Inc. Nutritional supplement for use under physiologically stressful conditions
US20080045548A1 (en) * 2006-08-21 2008-02-21 Astrazeneca Ab Pharmaceutical Compositions
TWI482772B (zh) * 2006-08-21 2015-05-01 Astrazeneca Ab 適合口服且包含三唑并[4,5-d]嘧啶衍生物之組合物
CA2671727C (en) * 2006-12-20 2016-02-16 Genpharm Ulc A composition containing a bisphosphonic acid in combination with vitamin d
RU2336073C1 (ru) * 2007-01-10 2008-10-20 Закрытое акционерное общество "Биологические исследования и системы" Пероральный лекарственный препарат тилорон
CN101772304B (zh) * 2007-07-31 2014-07-09 卡吉尔公司 直接可压缩的右旋糖
WO2009059605A1 (en) * 2007-11-08 2009-05-14 University Of Copenhagen Small scale solid state screening
PT2266581E (pt) * 2008-03-18 2016-01-27 Aleksander Vladimirovich Dikovskiy Composição farmacológica de antibióticos e prebióticos para prevenir e tratar disbiose durante terapia antibacteriana
WO2009116886A1 (ru) * 2008-03-18 2009-09-24 Dikovskiy Aleksander Vladimiro Фармацевтическая композиция и способ профилактики дисбиозов, ассоциированных с энтеральным приемом антибиотиков
US8106111B2 (en) 2009-05-15 2012-01-31 Eastman Chemical Company Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions
AR083417A1 (es) * 2010-10-14 2013-02-21 Novartis Ag Composiciones farmaceuticas que contienen un dgat1 inhibidor
WO2013088274A1 (en) 2011-12-14 2013-06-20 Wockhardt Limited Anhydrous amorphous azithromycin composition free of azithromycin dihydrate
KR20150092385A (ko) 2014-02-03 2015-08-13 씨제이헬스케어 주식회사 솔리페나신을 포함하는 안정한 제제 및 이의 제조방법
US20150243176A1 (en) 2014-02-24 2015-08-27 Mindojo Ltd. Virtual course boundaries in adaptive e-learning datagraph structures
US20160145548A1 (en) * 2014-11-20 2016-05-26 The Procter & Gamble Company Cleaning composition refill for an automatic dishwasher dispensing device
CN105193753A (zh) * 2015-10-30 2015-12-30 成都通德药业有限公司 一种阿奇霉素分散片的制备方法
CN110633487B (zh) * 2019-07-03 2023-03-14 北京中医药大学 直接压片的片剂处方的设计方法
CN111467362B (zh) * 2020-05-09 2021-07-06 北京四环制药有限公司 一种阿奇霉素药用组合物及其制备方法和其应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
WO1989000576A1 (en) * 1987-07-09 1989-01-26 Pfizer Inc. Azithromycin dihydrate
WO1989002271A1 (en) * 1987-09-10 1989-03-23 Pfizer Azithromycin and derivatives as antiprotozoal agents
US5047246A (en) * 1988-09-09 1991-09-10 Bristol-Myers Company Direct compression cyclophosphamide tablet
TW271400B (pl) * 1992-07-30 1996-03-01 Pfizer
US5795871A (en) * 1994-04-26 1998-08-18 Nobuhiro Narita Pharmaceutical composition for treatment of non-small cell lung cancer
US5605889A (en) * 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin
HUT77530A (hu) * 1994-05-06 1998-05-28 Pfizer Inc. Azitromicint tartalmazó, szabályozott hatóanyag-felszabadítású dózisformák
IL119866A (en) 1996-12-19 1999-12-31 Unipharm Ltd Antibiotic tablet
CO4920215A1 (es) 1997-02-14 2000-05-29 Novartis Ag Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones
US6339063B1 (en) * 1997-09-10 2002-01-15 Merck & Co., Inc. 9a-azalides as veterinary antimicrobial agents
ES2281136T3 (es) * 1997-09-10 2007-09-16 Merial Ltd. Uso de 9a-azalidos como agentes antimicrobiales veterinarios.
CA2245398C (en) * 1998-08-21 2002-01-29 Apotex Inc. Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
SI20639A (sl) * 1998-11-30 2002-02-28 Teva Pharmaceutical Industries Ltd. Etanolat azitromicina, postopek za njegovo pripravo in njegovi farmacevtski sestavki
FR2793690B1 (fr) * 1999-03-30 2003-01-03 Cll Pharma Formulations pharmaceutiques en macrolides seuls ou associes a d'autres principes actifs et leur utilisation en therapeutique
ES2177373B1 (es) 1999-11-26 2003-11-01 Astur Pharma Sa Preparacion de azitromicina en su forma no cristalina
CA2485433C (en) * 1999-11-26 2008-01-29 Astur Pharma S.A. Preparation of non-crystalline and crystalline dihydrate forms of azithromycin
WO2002009640A2 (en) 2000-08-01 2002-02-07 Shiva Prasad Singh Process for the preparation of anhydrous azithromycin
US6861413B2 (en) * 2001-05-22 2005-03-01 Pfizer Inc. Stable non-dihydrate azithromycin oral suspensions
ES2258142T3 (es) * 2001-05-22 2006-08-16 Pfizer Products Inc. Nueva forma cristalina.
ES2324527T3 (es) * 2001-10-18 2009-08-10 Teva Pharmaceutical Industries Ltd. Composiciones de azitromicina estabilizadas.
PL371259A1 (pl) * 2001-12-21 2005-06-13 Pfizer Products Inc. Bezpośrednio sprasowywalne preparaty azytromycyny
NZ532063A (en) * 2001-12-21 2006-03-31 Pfizer Prod Inc Methods for wet granulating azithromycin
RU2283092C2 (ru) * 2002-02-01 2006-09-10 Пфайзер Продактс Инк. Сухие гранулированные композиции азитромицина

Also Published As

Publication number Publication date
CA2469246A1 (en) 2003-07-03
IL161996A0 (en) 2005-11-20
PL371259A1 (pl) 2005-06-13
RU2004118709A (ru) 2005-04-20
ZA200403486B (en) 2006-05-31
US20060024364A1 (en) 2006-02-02
WO2003053416A1 (en) 2003-07-03
AR037930A1 (es) 2004-12-22
PY0231025A (es) 2004-07-01
US20030165563A1 (en) 2003-09-04
KR100632339B1 (ko) 2006-10-12
EP1455758A1 (en) 2004-09-15
RU2277914C2 (ru) 2006-06-20
KR20040066175A (ko) 2004-07-23
MXPA04005105A (es) 2004-08-19
CN1668282A (zh) 2005-09-14
US7070811B2 (en) 2006-07-04
TW200301138A (en) 2003-07-01
JP2005513099A (ja) 2005-05-12
US20060024363A1 (en) 2006-02-02
PA8562201A1 (es) 2003-07-28
AU2002348884A1 (en) 2003-07-09
BR0215193A (pt) 2004-11-16
NZ532707A (en) 2006-07-28
US20050287209A1 (en) 2005-12-29
PE20030591A1 (es) 2003-07-12

Similar Documents

Publication Publication Date Title
NO20043110L (no) Direkte komprimerbare formuleringer av azitromycin
PT1250343E (pt) Composicoes de antibioticos de azalida
EE200300575A (et) Asitromütsiini kristalsed vormid
AR028567A1 (es) Nuevos derivados de fenil-propargileter
ATE402148T1 (de) Substituierte pyridinylamine
PT1406628E (pt) Derivados de tera-hidroquinolina
NO20040125L (no) Enterale formuleringer
DE60218175D1 (de) Stabilisierte orale suspensionsformulierung
AR028596A1 (es) Nuevos derivados de fenilglicina
EP1349613A4 (en) THROMBOPOIETINMIMETIKA
PT1250321E (pt) Composicao de gliburida
ID30187A (id) Dongkrak jenis pantagraf
DE50206892D1 (de) Substituierte imidazotriazinone
NO20041968L (no) Anvendelse av cystationin
PT1322592E (pt) Derivados substituidos de 1-aminobutan-3-ol
ATE435197T1 (de) Substituierte 4-aminocyclohexanole
ATE268116T1 (de) Mesotrion-formulierungen
PT1392670E (pt) Derivados substituidos de c-furan-2-il-metilamina e c-tiofen-2-il-metilamina
FI20011778A0 (fi) Ryhmälähetyksen toteutus
FI20012295A0 (fi) Hyvyysluku
NO20020524D0 (no) Stabiliserte organisk-peroksid sammensetninger
DK1230832T3 (da) Plov
FI20011441A0 (fi) Levitysjärjestely
DK1358781T3 (da) Faceplate
NO20042074L (no) Makrolider inneholdende farmasoytiske sammensetninger

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application
ERR Erratum

Free format text: I PATENTTIDENDE NR 05/37 BLE PATENTSOKNAD NR. 20043110 VED EN FEIL KUNNGJORT HENLAGT. SOKNADEN ER FORTSATT UNDER BEHANDLING.

FC2A Withdrawal, rejection or dismissal of laid open patent application